These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3533075
1. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition. Plattner JJ, Greer J, Fung AK, Stein H, Kleinert HD, Sham HL, Smital JR, Perun TJ. Biochem Biophys Res Commun; 1986 Sep 30; 139(3):982-90. PubMed ID: 3533075 [Abstract] [Full Text] [Related]
2. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. Bolis G, Fung AK, Greer J, Kleinert HD, Marcotte PA, Perun TJ, Plattner JJ, Stein HH. J Med Chem; 1987 Oct 30; 30(10):1729-37. PubMed ID: 3309313 [Abstract] [Full Text] [Related]
3. Renin inhibitors containing psi[CH2O] pseudopeptide inserts. TenBrink RE, Pals DT, Harris DW, Johnson GA. J Med Chem; 1988 Mar 30; 31(3):671-7. PubMed ID: 3279210 [Abstract] [Full Text] [Related]
4. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency. Luly JR, BaMaung N, Soderquist J, Fung AK, Stein H, Kleinert HD, Marcotte PA, Egan DA, Bopp B, Merits I. J Med Chem; 1988 Dec 30; 31(12):2264-76. PubMed ID: 3143009 [Abstract] [Full Text] [Related]
5. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site. Sueiras-Diaz J, Jones DM, Szelke M, Leckie BJ, Beattie SR, Beattie C, Morton JJ. J Pept Res; 1997 Oct 30; 50(4):239-47. PubMed ID: 9352462 [Abstract] [Full Text] [Related]
6. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond. Harada H, Iizuka K, Kamijo T, Akahane K, Yamamoto R, Nakano Y, Tsubaki A, Kubota T, Shimaoka I, Umeyama H. Chem Pharm Bull (Tokyo); 1990 Nov 30; 38(11):3042-7. PubMed ID: 2085885 [Abstract] [Full Text] [Related]
7. New renin inhibitors containing novel analogues of statine. Jones DM, Sueiras-Diaz J, Szelke M, Leckie BJ, Beattie SR, Morton J, Neidle S, Kuroda R. J Pept Res; 1997 Aug 30; 50(2):109-21. PubMed ID: 9273895 [Abstract] [Full Text] [Related]
8. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid. Johnson RL, Verschoor K. J Med Chem; 1983 Oct 30; 26(10):1457-62. PubMed ID: 6352942 [Abstract] [Full Text] [Related]
9. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site. Smith CW, Saneii HH, Sawyer TK, Pals DT, Scahill TA, Kamdar BV, Lawson JA. J Med Chem; 1988 Jul 30; 31(7):1377-82. PubMed ID: 3290486 [Abstract] [Full Text] [Related]
10. Conformational aspects of angiotensinogen analogues with renin inhibitory activity. Liepina I, Nikiforovich GV, Paiva AC. Biochem Biophys Res Commun; 1984 Jul 31; 122(2):700-5. PubMed ID: 6380499 [Abstract] [Full Text] [Related]
11. Peptide inhibitors of renin in cardiovascular studies. Haber E. Fed Proc; 1983 Dec 31; 42(15):3155-61. PubMed ID: 6196232 [Abstract] [Full Text] [Related]
13. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions. Paschalidou K, Neumann U, Gerhartz B, Tzougraki C. Biochem J; 2004 Sep 15; 382(Pt 3):1031-8. PubMed ID: 15233625 [Abstract] [Full Text] [Related]
14. New inhibitors of human renin that contain novel Leu-Val replacements. Luly JR, Yi N, Soderquist J, Stein H, Cohen J, Perun TJ, Plattner JJ. J Med Chem; 1987 Sep 15; 30(9):1609-16. PubMed ID: 3305946 [Abstract] [Full Text] [Related]
15. Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective. Sawyer TK, Hester JB, Schostarez HJ, Thaisrivongs S, Bundy GL, Liu L, Bradford VS, De Vaux AE, Staples DJ, Maggiora LL. Adv Exp Med Biol; 1991 Sep 15; 306():307-23. PubMed ID: 1812721 [No Abstract] [Full Text] [Related]
16. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin. Nakagawa T, Akaki J, Satou R, Takaya M, Iwata H, Katsurada A, Nishiuchi K, Ohmura Y, Suzuki F, Nakamura Y. Biol Chem; 2007 Feb 15; 388(2):237-46. PubMed ID: 17261087 [Abstract] [Full Text] [Related]
17. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension. Burton J, Cody RJ, Herd JA, Haber E. Proc Natl Acad Sci U S A; 1980 Sep 15; 77(9):5476-9. PubMed ID: 6159648 [Abstract] [Full Text] [Related]
18. Inhibition of renin in the primate Callithrix jacchus (common marmoset). Hofbauer KG, Ménard J, Michel JB, Wood JM. Clin Exp Hypertens A; 1983 Sep 15; 5(7-8):1237-47. PubMed ID: 6196144 [Abstract] [Full Text] [Related]
19. Will renin inhibitors influence decision-making in antihypertensive therapy? Haber E. J Hypertens Suppl; 1985 Nov 15; 3(2):S71-80. PubMed ID: 3003303 [Abstract] [Full Text] [Related]